p53 expression is of independent predictive value in lymph node-negative breast carcinoma

European Journal of Cancer Part A

Volumn 33, Issue 8, 1997, Pages 1268-1274

  Fresno, M ^a   Molina, R ^a   Perez Del Rio M J ^a   Alvarez, S ^a   Diaz Iglesias J M ^a   Garcia I ^a   Herrero, A ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Breast carcinoma; Immunohistochemistry; Oncoprotein; p53

Indexed keywords

AVIDIN; BIOTIN; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PEROXIDASE; PROTEIN P53;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR NECROSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL DIVISION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030796950     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00096-8     Document Type: Article

References (43)

1. Thorpe SM, Rose C, Rasmussen BB, Mouridsen HT, Bayer T, Keiding N. On the behalf of the Danish Breast Cancer Cooperative Group. Cancer Res 1987, 47, 6126-6133.
2. Hollingsworth RE, Lee WH. Tumor suppressor genes: New prospects for cancer research. J Natl Cancer Inst 1991, 83, 91-96.
3. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989, 57, 1083-1093.
4. Levine AJ, Momad J, Finley CA. The p53 tumor suppressor gene. Nature 1991, 351, 453-456.
5. Nigro JM, Baker S, Preisinger A, et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1987, 342, 705-708.
6. Wynford-Thomas D. Oncogenes and anti-oncogenes: The molecular basis of tumor behavior. J Pathol 1991, 165, 187-201.
7. Sturzbecher HW, Maimets T, Chumakow P, et al. p53 interacts in mammalian cells: implications for cell cycle control and oncogenesis. Oncogene 1990, 5, 795-801.
8. Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990, 249, 912-915.
9. Mercer WE, Shields MT, Lin D, Appella E, Ullrich SJ. Growth suppressor induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating cell nuclear antigen expression. Proc Natl Acad Sci 1990, 88, 1958-1962.
10. Iggo R, Gatter K, Bartek J, et al. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990, 35, 675-679.
11. Lohmann D, Ruhri C, Schmitt M, Graeff H, Hofler H. Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives. Diagnost Mol Pathol 1993, 2, 36-41.
12. Hurlimann J, Chaubert P, Benhattar J. p53 gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques. Mod Pathol 1994, 7, 423-428.
13. Fields S, Jang SK. Presence of a potent transcription activating sequence in the p53 protein. Science 1992, 249, 1046-1051.
14. Lane DP, Benchimol S. p53: oncogene or anti-oncogene. Genes Devel 1990, 4, 1-8.
15. Poller DN, Roberts EC, Bell JA, et al. p53 protein expression in mammary ductal carcinoma in situ. Relationship to immunohistochemical expression of oestrogen receptor and c-erbB-2 protein. Human Pathol 1993, 24, 463-468.
16. Barbareschi M, Leonardi E, Mauri FA, Serio G, Palma P. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer. Am J Clin Pathol 1992, 98, 408-418.
17. Barnes DM, Dublin EA, Fisher CJ, et al. Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator or prognosis? Hum Pathol 1993, 24, 469-476.
18. Martinazzi M, Crivelli F, Zampatti C, Martinazzi S. Relationship between p53 expression and other prognostic factors in human breast carcinoma. An immunohistochemical study. Am J Clin Pathol 1993, 100, 213-217.
19. Isola J, Visakorpi T, Holli K, Kallioneimi OP. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 1992, 84, 1109-1114.
20. Marks JV, Davidoff AM, Kerns BJ, et al. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 1991, 51, 2979-2984.
21. Chang K, Ding I, Kern FG, Willinghan MC. Immunohistochemical analysis of p53 and HER-2/neu proteins in human tumors. J Histochem Cytochem 1991, 39, 1281-1287.
22. Barbareschi M, Girlando S, Mauri FA, et al. Tumor suppressor gene products, proliferation and differentiation markers expression in lung neuroendocrine neoplasms. J Pathol 1992, 166, 343-350.
23. Wright C, Mellon K, Johnston P, et al. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 1991, 63, 967-970.
24. Moch H, Sauter G, Moore D, Mihatsch MJ, Gudat F, Waldman F. p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer. Virch Arch A Pathol Anat 1993, 423, 329-334.
25. Lipponen P. Overexpression of nuclear oncoprotein in transitional cell bladder cancer and its prognostic value. Int J Cancer 1993, 53, 365-370.
26. Campo E, Call e-Martin O de la, Miquel R, et al. Loss of heterozygosity of the p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res 1991, 51, 4436-4442.
27. Purdie CA, O'Grady J, Piris J, et al. p53 expression in colorectal tumors. Am J Pathol 1991, 138, 807-813.
28. Ostrowsky JL, Sawan A, Henry C, et al. p53 expression in human breast related to survival and prognostic factors: an immunohistochemical study. J Pathol 1991, 164, 75-81.
29. Sawan A, Randall B, Angus B, et al. Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: an immunohistochemical study. J Pathol 1992, 168, 23-28.
30. Lipponen P, Aaltomaa HJ, Syrjänen S, Syrjän P. p53 protein expression in breast cancer as related to histopathological characteristics and prognosis. Int J Cancer 1993, 55, 51-56.
31. Silvestrini R, Benini E, Diadone MG, Veneroni S, Boracchi P. p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 1993, 85, 965-970.
32. Battifora H. p53. A word of caution. Human Pathol 1994, 25, 435-437.
33. Bosari S, Lee A, Viale G, Heatley GJ, Coggi G. Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up. Virch Arch A Pathol Ant 1992, 421, 291-295.
34. Elledge RM, Clark GM, Fuqua SAW, Yu YY, Allred DC. p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer. Cancer Res 1994, 54, 3752-3757.
35. Rosen PP, Lesser ML, Arroyo CD, Cranor M, Borgen P, Norton L. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. J Clin Oncol 1995, 13, 821-830.
36. Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993, 85, 200-206.
37. Bartek J, Bartkova J, Vojtesek B, et al. Pattern of expression of the p53 tumor suppressor gene in human breast tissue and tumors in situ and in vitro. Int J Cancer 1990, 46, 839-844.
38. Cattoretti G, Rilke F, Andreola S, et al. p53 expression in breast cancer. Int J Cancer 1988, 41, 178-183.
39. Umekita Y, Takasaki T, Yoshida H. Expression of p53 in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive mammary carcinoma: an immunohistochemical study. Virch Arch 1994, 424, 491-494.
40. Gorczyca W, Markiewski M, Kram A, Tuziak T, Dornagala W. Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction. Virch Arch 1995, 426, 229-233.
41. Thor AD, Moore DH, Edgerton SM, et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992, 84, 845-855.
42. Friedrichs K, Gluba S, Eidtmann H, Jonat W. Overexpression of p53 and prognosis in breast cancer. Cancer 1993, 72, 3641-3647.
43. Davidoff AM, Herndon JE, Glover NS, et al. Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery 1991, 110, 259-264.